Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Uveal Melanoma × Immunotherapy × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Squamous Cell Carcinoma of Head and Neck 2 Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Sarcoma 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Head and Neck Neoplasms 1 Glioblastoma 1 Cholangiocarcinoma 1 Brain Neoplasms 1

Interventions

Ipilimumab 5 pembrolizumab 4 Nivolumab 4 Dacarbazine 4 CTLA-4 Antigen 3 aflibercept 2 Temozolomide 2 Ranibizumab 2 Radiosurgery 2 Paclitaxel 2 Lenalidomide 2 Cyclophosphamide 2 Carboplatin 2 Bevacizumab 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 utomilumab 1 ulixertinib 1 trametinib 1 tebentafusp 1 sotrastaurin 1 sargramostim 1 relatlimab 1 poly ICLC 1 pasireotide 1 omipalisib 1 oblimersen 1 niraparib 1 lenvatinib 1 glembatumumab vedotin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡